The antimicrobial peptide LL-37 alters human osteoblast Ca handling and induces Ca2+-independent apoptosis

Journal of Innate Immunity

Volumn 5, Issue 3, 2013, Pages 290-300

  Säll, Johanna ^a   Carlsson, Martin ^a,c   Gidlöf, Olof ^b   Holm, Anders ^a   Humlén, Johan ^a,c   Öhman, Jenny ^b   Svensson, Daniel ^a   Nilsson, Bengt Olof ^a   Jönsson, Daniel ^a,c  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c MALMÖ UNIVERSITY   (Sweden)

Author keywords

Annexin V; Apoptosis; Calcium; Caspase 3; LL 37; Osteoblast

Indexed keywords

CALCIUM ION; CASPASE 3; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; LIPOCORTIN 5; NIFEDIPINE; 15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; CALCIUM; STAUROSPORINE; TRYPAN BLUE;

APOPTOSIS; ARTICLE; CALCIUM CELL LEVEL; CELL COUNT; CELL VIABILITY; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IC 50; IMMUNOMODULATION; OSTEOBLAST; PRIORITY JOURNAL; CELL CULTURE; CELL STRUCTURE; CONFOCAL MICROSCOPY; EXTRACELLULAR CALCIUM; FLOW CYTOMETRY; IC50; LASER SCANNING CONFOCAL MICROSCOPY;

ANNEXIN A5; ANTIMICROBIAL CATIONIC PEPTIDES; APOPTOSIS; CALCIUM; CALCIUM CHANNELS, L-TYPE; CALCIUM CHANNELS, T-TYPE; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; OSTEOBLASTS;

EID: 84876791989     PISSN: 1662811X     EISSN: 16628128     Source Type: Journal    
DOI: 10.1159/000346587     Document Type: Article

References (40)

1. Gudmundsson GH, Agerberth B, Odeberg J, Bergman T, Olsson B, Salcedo R: The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes. Eur J Biochem 1996; 238: 325-332. (Pubitemid 26188246)
2. Sorensen OE, Follin P, Johnsen AH, Calafat J, Tjabringa GS, Hiemstra PS, Borregaard N: Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. Blood 2001; 97:3951-3959.
3. Burton MF, Steel PG: The chemistry and biology of LL-37. Nat Prod Rep 2009; 26:1572-1584.
4. Turner J, Cho Y, Dinh NN, Waring AJ, Lehrer RI: Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils. Antimicrob Agents Chemother 1998; 42: 2206-2214. (Pubitemid 28420351)
5. Nizet V, Ohtake T, Lauth X, Trowbridge J, Rudisill J, Dorschner RA, Pestonjamasp V, Piraino J, Huttner K, Gallo RL: Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 2001; 414:454-457. (Pubitemid 34173727)
6. Larrick JW, Hirata M, Balint RF, Lee J, Zhong J, Wright SC: Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein. Infect Immun 1995; 63:1291-1297.
7. Nijnik A, Pistolic J, Filewod NCJ, Hancock REW: Signaling pathways mediating chemokine induction in keratinocytes by cathelicidin LL-37 and flagellin. J Innate Immun 2012; 4:377-386.
8. Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR, Ochoa MT, Schauber J, Wu K, Meinken C, Kamen DL, Wagner M, Bals R, Steinmeyer A, Zügel U, Gallo RL, Eisenberg D, Hewison M, Hollis BW, Adams JS, Bloom BR, Modlin RL: Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006; 311:1770-1773.
9. Zhang Z, Shively JE: Generation of novel bone forming cells (monoosteophils) from the cathelicidin-derived peptide LL-37 treated monocytes. PLoS One 2010; 5:e13985.
10. Ciornei CD, Tapper H, Bjartell A, Sternby NH, Bodelsson M: Human antimicrobial peptide LL-37 is present in atherosclerotic plaques and induces death of vascular smooth muscle cells: a laboratory study. BMC Cardiovasc Disord 2006; 6:49.
11. Jönsson D, Nilsson BO: The antimicrobial peptide LL-37 is anti-inflammatory and proapoptotic in human periodontal ligament cells. J Periodont Res 2012; 47:330-335.
12. Zhang Z, Cherryholmes G, Shively JE: Neutrophil secondary necrosis is induced by LL-37 derived from cathelicidin. J Leukoc Biol 2008; 84:780-788.
13. Mader JS, Ewen C, Hancock RE, Bleackley RC: The human cathelicidin, LL-37, induces granzyme-mediated apoptosis in regulatory T cells. J Immunother 2011; 34:229-235.
14. Barlow PG, Beaumont PE, Cosseau C, Mackellar A, Wilkinson TS, Hancock RE, Haslett C, Govan JR, Simpson AJ, Davidson DJ: The human cathelicidin LL-37 preferentially promotes apoptosis of infected airway epithelium. Am J Respir Cell Mol Biol 2010; 43:692-702.
15. Chamorro CI, Weber G, Gronberg A, Pivarcsi A, Stahle M: The human antimicrobial peptide LL-37 suppresses apoptosis in keratinocytes. J Invest Dermatol 2009; 129:937-944.
16. Kim HJ, Cho DH, Lee KJ, Cho CS, Bang SI, Cho BK, Park HJ: LL-37 suppresses sodium nitroprusside-induced apoptosis of systemic sclerosis dermal fibroblasts. Exp Dermatol 2011; 20:843-845.
17. Nagaoka I, Tamura H, Hirata M: An antimicrobial cathelicidin peptide, human CAP18/LL-37, suppresses neutrophil apoptosis via the activation of formyl-peptide receptor-like 1 and P2X7. J Immunol 2006; 176:3044-3052.
18. Turkoglu O, Emingil G, Kutukculer N, Atilla G: Gingival crevicular fluid levels of cathelicidin LL-37 and interleukin-18 in patients with chronic periodontitis. J Periodontol 2009; 80: 969-976.
19. Lerner UH: Inflammation-induced bone remodeling in periodontal disease and the influence of post-menopausal osteoporosis. J Dent Res 2006; 85:596-607. (Pubitemid 44085948)
20. Orrenius S, Nicotera P: The calcium ion and cell death. J Neural Transm Suppl 1994; 43: 1-11. (Pubitemid 24362355)
21. Berridge MJ, Lipp P, Bootman MD: The versatility and universality of calcium signaling. Nat Rev Cell Biol 2000; 1:11-21.
22. Elssner A, Duncan M, Gavrilin M, Wewers MD: A novel P2X7 receptor activator, the human cathelicidin-derived peptide LL37, induces IL-1 beta processing and release. J Immunol 2004; 172:4987-4994. (Pubitemid 38456425)
23. Tjabringa GS, Aarbiou J, Ninaber DK, Drijfhout JW, Sorensen OE, Borregaard N, Rabe KF, Hiemstra PS: The antimicrobial peptide LL-37 activates innate immunity at the airway epithelial surface by transactivation of the epidermal growth factor receptor. J Immunol 2003; 171:6690-6696. (Pubitemid 37532101)
24. von Haussen J, Koczulla R, Shaykhiev R, Herr C, Pinkenburg O, Reimer D, Wiewrodt R, Biesterfeld S, Aigner A, Czubayko F, Bals R: The host defence peptide LL-37/hCAP-18 is a growth factor for lung cancer cells. Lung Cancer 2008; 59:12-23.
25. Coffelt SB, Waterman RS, Florez L, Bentrup KH, Zwezdaryk KJ, Tomchuck SL, LaMarca HL, Danka ES, Morris CA, Scandurro AB: Ovarian cancers overexpress the antimicrobial protein hCAP-18 and its derivative LL-37 increases ovarian cancer cell proliferation and invasion. Int J Cancer 2008; 122:1030-1039. (Pubitemid 351214000)
26. Nygren PA: Alternative binding proteins: affibody binding proteins developed from a small three-helix bundle scaffold. FEBS J 2008; 275:2668-2676.
27. Kraus D, Deschner J, Jäger A, Wenghoefer M, Bayer S, Jepsen S, Allam JP, Novak N, Meyer R, Winter J: Human β-defensins differently affect proliferation, differentiation, and mineralization of osteoblast-like MG63 cells. J Cell Physiol 2012; 227:994-1003.
28. Kawano M, Ariyoshi W, Iwanaga K, Okinaga T, Habu M, Yoshioka I, Tominaga K, Nishihara T: Mechanism involved in enhancement of osteoblast differentiation by hyaluronic acid. Biochem Biophys Res Commun 2011; 405:575-580.
29. 2+ mobilization is a prerequisite to apoptosis in HeLa cells. Apoptosis 2012; 17: 821-831.
30. 2+ stores. J Biol Chem 1993; 268:6945-6952. (Pubitemid 23105577)
31. 3. Am J Physiol Cell Physiol 2006; 290:C822-C831.
32. Burns DM, Stehno-Bittel L, Kawase T: Calcitonin gene related peptide elevates calcium and polarizes membrane potential in MG-63 cells by both cAMP-independent and -dependent mechanisms. Am J Physiol Cell Physiol 2004; 287:C457-C467. (Pubitemid 38955237)
33. Bhattacharjee A, Whitehurst RM, Zhang M, Wang L, Li M: T-type calcium channels facilitate insulin secretion by enhancing general excitability in the insulin-secreting β-cell line, INS-1. Endocrinology 1997; 138:3735-3740. (Pubitemid 27351923)
34. 7 receptor antagonists. Br J Pharmacol 2009; 156:1312-1325.
35. Ong PY, Ohtake T, Brandt C, Strickland I, Boguniewicz M, Ganz T, Gallo RL, Leung DY: Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 2002; 347:1151-1160.
36. Yamasaki K, Di Nardo A, Bardan A, Murakami M, Ohtake T, Coda A, Dorschner RA, Bonnart C, Descargues P, Hovnanian A, Morhenn VB, Gallo RL: Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea. Nat Med 2007; 13: 975-980. (Pubitemid 47222043)
37. Schauber J, Rieger D, Weiler F, Wehkamp J, Eck M, Fellermann K, Scheppach W, Gallo RL, Stange EF: Heterogeneous expression of human cathelicidin hCAP18/LL-37 in inflammatory bowel diseases. Eur J Gastroenterol Hepatol 2006; 18:615-621. (Pubitemid 43804644)
38. 2+ and apoptosis. Cell Calcium 2012; 52:36-43.
39. Shabbir M, Ryten M, Thompson C, Mikhailidis D, Burnstock G: Characterization of calcium-independent purinergic receptor-mediated apoptosis in hormone-refractory prostate cancer. BJU Int 2008; 101:352-359.
40. i elevation. Toxicol Sci 2007; 100: 109-117.